Earnout Achievement Insights from the 2025 SRS Acquiom Life Sciences M&A Study
Explore key earnout achievement insights from the 2025 SRS Acquiom Life Sciences M&A Study, including a focused look at life sciences M&A milestone achievement broken down by:
- Industry sector: Biotechnology & Pharmaceuticals, Medical Devices, and Diagnostic Research Technologies
- Structure: Commercial vs. development milestones
- Timing: Impact when performance periods run longer
This info sheet draws on our expansive 2025 Life Sciences M&A Study, which features data-driven insights from 466 private-target life sciences transactions, including 342 with an earnout and 242 that had at least one milestone due by mid-2025. Based on a mature, 15-year data set, the study explores how often earnouts pay, which factors might influence milestone success, and more.
Download This Document
Once submitted, you will receive an email confirmation. If you have any questions, please email our team at learnmore@srsacquiom.com.